Member Info for HarriM

Agreed re. data collection.

Hoping the route to doing this is distinctly alternative- treatment of individuals with SNG001 with their consent, where SNG001 is touted as an experimental drug, to bolster numbers.

Will be revealed shortly either way

As yu said it's phase II, because of numbers (100). My thinking is the second phase of the trial, should it be successful, would bolster numbers nearer to phase III. The goal of phase III is to determine a drug's therapeutic effect, which they they seem to have determiend

Is flawed as is the writer's lack of understanding of the scientific process and emergency approval. Although 100 individuals is a smallish study, it's enough to show efficacy of a drug and was the study not in fact phase II/phase III? I'm expecting publication of the entire set of COVID19 data in a good journal shortly, in addition to the COPD results. Was lucky enough to invest in Synairgen a few days before the rise because of the publication showing complete depletion of interfeon beta in severely affected COVID19 individuals.

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients by Hadjadj et al

Other publications have also found depletion or impaired production in COVID.

https://www.delisted.com.au/company/battle-mountain-gold-company
According to the above link Battle Mountain is a subsidiary of Newmont and became so in 2001

https://leafyquick.com/collections/cbd-oil

They have the most reviews, all 5* and are the first product on the webpage. Will be huge, once they start selling the seed. Hemp is now seen as a much more durable, sustainable alternative to cotton and grows three times as quickle. There are multiple uses for it. Hemp isn't cannabis, people have to be made aware of this.

Also Nick Tullock seems very quick off the mark and a doer, was the managing director for Corporate Finance at Cantor. Much rather he at the helm of this company.